Pilatus Clinical Services - German Subsidiary PCS GMBH Awarded WDL GDP Certificate

Food and Healthcare Press Releases Wednesday March 14, 2018 15:00
LONDON--14 Mar--PRNewswire/InfoQuest

As part of Pilatus Clinical Services ongoing plans to strengthen its position in Europe and as part of establishing a Global footprint, the company has announced that following a recent inspection by the German regulatory authorities, its German facilities in Brandenburg have been granted a WDL/GDP Certificate.

Managing Director, Philipp Hofmann says, "We have now been established and trading since April 4th 2017, but it was imperative that we are geared up to be in a position to operate under this WDL/GDP Certificate. I am proud of the dedication put in by the team to ensure that we received the go ahead from the regulatory authorities in record time."

This will greatly strengthen Pilatus Clinical Services' position in Europe and enhance its access to manufacturers and suppliers in Europe, to transform the service offered to clients.
With Brexit looming, this move will also mitigate any risk of exposure to Pilatus Clinical services and our Clients.
Management of end to end supply chain, so you don't have to worry about it. To find more out about Pilatus Clinical Services, please take a look at our website http://www.pilatusclinicalservices.com/
Contact details for PCS GMBH:
+49-3328-428-9909
p.hofmann@pilatuscs.com
http://www.pcs-deutschland.com
PCS GmbH, Mahlowerstr. 249, 14513 Teltow,
Amtsgericht Potsdam| HRB 30039 P | USt-IdNr. DE312595524
Source: Pilatus Clinical Services

Latest Press Release

The Menarini Group Announces Meropenem/vaborbactam European Marketing Authorization

- Meropenem/vaborbactam approved on 20th November 2018 by the European Commission for clinical use in adult patients with difficult-to-treat infections - The first combination of a carbapenem and a beta-lactamase inhibitor approved for clinical use in...

Merck Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer

- FDA grants M7824, an investigational bifunctional immunotherapy, orphan drug designation in biliary tract cancer - First regulatory designation for M7824 following recent presentation of first clinical data in BTC - BTC is a group of rare, aggressive...

Merck in Agreement With Cyclica for AI-augmented Screening Platform to Expand Research Capabilities

- Agreement to screen discovery and early development compounds using artificial intelligence and computational biophysics - Cloud-based in silico platform that screens small molecules to determine polypharmacological profiles - Evaluation to include...

Vitality-linked Insurers to Get 100 million People 20% More Active by 2025

Building on the results of the largest behaviour change study on physical activity, Vitality and its global network of insurers have collectively committed to improving the health of millions over the next seven years. This is in line with the World...

World Congress of Cardiology Cardiovascular Health 2018 Opens in Dubai

- Professor David Wood, President of the World Heart Federation, welcomes more than 5000 cardiologists, doctors, nurses, and health and policy experts from around the world to Dubai for WCC 2018 at a time when the opportunities for a sustainable impact...

Related Topics